Bone Biologics (BBLG) Preferred Shares (2016)

Bone Biologics (BBLG) reported Preferred Shares of $1.8 million for Q4 2016.

Bone Biologics (BBLG) Preferred Shares (2016) Analysis & Trends

Bone Biologics (BBLG) has 1 years of Preferred Shares data on file, last reported at $1.8 million in Q4 2016.

Preferred Shares for Q4 2016 came in at $1.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2016 was $1.8 million (changed N/A YoY), and the FY2016 annual result was $1.8 million, changed N/A from the prior year.
Preferred Shares steadied at $1.8 million in Q4 2016 per BBLG's latest filing.
Over five years, Preferred Shares peaked at $1.8 million in Q4 2016 and troughed at $1.8 million in Q4 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-
9	Abivax	95.45 Bn	95.45 Bn	-	-
10	Bone Biologics	1.47 Mn	1.47 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2016	1.82 Mn